Katy Bradford: Cassette approach offers compelling construction solution
Filter News
Area of Research
- (-) Neutron Science (19)
- (-) Nuclear Science and Technology (35)
- Advanced Manufacturing (4)
- Biological Systems (1)
- Biology and Environment (10)
- Clean Energy (53)
- Climate and Environmental Systems (1)
- Computational Engineering (1)
- Computer Science (9)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (4)
- Fusion Energy (8)
- Isotopes (4)
- Materials (47)
- Materials for Computing (3)
- National Security (12)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Quantum information Science (6)
- Sensors and Controls (1)
- Supercomputing (64)
News Topics
- (-) Artificial Intelligence (1)
- (-) Biomedical (10)
- (-) Computer Science (10)
- (-) Isotopes (5)
- (-) Machine Learning (2)
- (-) Microscopy (2)
- (-) Nuclear Energy (32)
- (-) Security (1)
- (-) Sustainable Energy (2)
- 3-D Printing/Advanced Manufacturing (7)
- Advanced Reactors (11)
- Big Data (1)
- Bioenergy (6)
- Clean Water (1)
- Climate Change (1)
- Composites (1)
- Coronavirus (6)
- Cybersecurity (1)
- Decarbonization (1)
- Energy Storage (3)
- Environment (6)
- Fusion (7)
- Materials Science (12)
- Mathematics (1)
- Molten Salt (4)
- Nanotechnology (6)
- National Security (1)
- Neutron Science (48)
- Physics (6)
- Polymers (1)
- Quantum Science (4)
- Space Exploration (4)
- Summit (5)
- Transformational Challenge Reactor (3)
- Transportation (2)
Media Contacts
The United Kingdom’s National Nuclear Laboratory and the U.S. Department of Energy’s Oak Ridge National Laboratory have agreed to cooperate on a wide range of nuclear energy research and development efforts that leverage both organizations’ unique expertise and capabilities.
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.